These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7155165)

  • 1. Cytogenetic distinction between the TK+ and TK- chromosomes in the L5178Y TK+/- 3.7.2C mouse-lymphoma cell line.
    Hozier J; Sawyer J; Clive D; Moore M
    Mutat Res; 1982 Dec; 105(6):451-6. PubMed ID: 7155165
    [No Abstract]   [Full Text] [Related]  

  • 2. High-resolution cytogenetic characterization of the L5178Y TK+/- mouse lymphoma cell line.
    Sawyer JR; Moore MM; Hozier JC
    Mutat Res; 1989 Oct; 214(2):181-93. PubMed ID: 2797024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis of the L5178Y/TK+/- leads to TK-/- mouse lymphoma mutagenesis assay system.
    Hozier J; Sawyer J; Moore M; Howard B; Clive D
    Mutat Res; 1981 Nov; 84(1):169-81. PubMed ID: 7329431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution cytogenetic analysis of L5178Y TK+/- 3.7.2C cells: variation in chromosome 11 breakpoints among small-colony TK-/- mutants.
    Hozier JC; Sawyer JR; Moore MM
    Mutat Res; 1989 Oct; 214(2):195-9. PubMed ID: 2797025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic characterization of the L5178Y TK+/-3.7.2C mouse lymphoma cell line.
    Sawyer J; Moore MM; Clive D; Hozier J
    Mutat Res; 1985 Oct; 147(5):243-53. PubMed ID: 4047079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells.
    Applegate ML; Moore MM; Broder CB; Burrell A; Juhn G; Kasweck KL; Lin PF; Wadhams A; Hozier JC
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):51-5. PubMed ID: 1967496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells.
    Moore-Brown MM; Clive D; Howard BE; Batson AG; Johnson KO
    Mutat Res; 1981 Oct; 85(5):363-78. PubMed ID: 6795499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of chromosome aberration frequency and small-colony TK-deficient mutant frequency in L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Moore MM; Doerr CL
    Mutagenesis; 1990 Nov; 5(6):609-14. PubMed ID: 2263219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
    Moore MM; Applegate ML; Hozier JC
    Mutat Res; 1988 Feb; 207(2):77-82. PubMed ID: 2448615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation capabilities of S9 liver fraction from 3 species in the L5178Y mouse-lymphoma assay.
    Oberly TJ; Piper CE; McDonald DS
    Mutat Res; 1982 Dec; 105(6):439-44. PubMed ID: 6818472
    [No Abstract]   [Full Text] [Related]  

  • 11. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of P53 heterozygosity is not responsible for the small colony thymidine kinase mutant phenotype in L5178Y mouse lymphoma cells.
    Clark LS; Harrington-Brock K; Wang J; Sargent L; Lowry D; Reynolds SH; Moore MM
    Mutagenesis; 2004 Jul; 19(4):263-8. PubMed ID: 15215324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the L5178Y TK+/- mouse lymphoma forward mutation assay using 42 chemicals.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1984 Feb; 125(2):291-306. PubMed ID: 6700611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1987 Mar; 187(3):141-9. PubMed ID: 3821767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxicity of gamma-irradiation in L5178Y mouse lymphoma cells.
    Moore MM; Amtower A; Strauss GH; Doerr C
    Mutat Res; 1986 Jun; 174(2):149-54. PubMed ID: 3713733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
    Clive D; Turner N; Krehl R
    Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of small colony trifluorothymidine-resistant mutants of L5178Y/TK+/- mouse lymphoma cells in RPMI-1640 medium.
    Moore MM; Howard BE
    Mutat Res; 1982; 104(4-5):287-94. PubMed ID: 6810164
    [No Abstract]   [Full Text] [Related]  

  • 18. The cytotoxic and mutagenic effects of UVA radiation on L5178Y mouse lymphoma cells.
    Hitchins VM; Withrow TJ; Olvey KM; Harleston BA; Ellingson OL; Bostrom RG
    Photochem Photobiol; 1986 Jul; 44(1):53-7. PubMed ID: 3749293
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the genotoxicity of vincristine and colchicine using mouse lymphoma tk mutation assay].
    Wang YJ; Zhang LS
    Wei Sheng Yan Jiu; 2006 Mar; 35(2):179-81. PubMed ID: 16758965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TK locus mutation assay: comparison of L5178Y and TK6 cell lines].
    Shuai PQ; Zhang LS; Wang YJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):650-3. PubMed ID: 15460410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.